Corcept Therapeutics | CORT - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Ardelyx USD 94.47M 30.74M 2026-03
Aurora Cannabis CAD 38.01M 56.18M 2026-03
BioMarin Pharmaceutical USD 990M 224M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
J&J USD 25.31B 1.21B 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.6B 310M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Pacira USD 192.4M 15.4M 2026-06
Pfizer USD 15.03B 530M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06